ClinicalTrials.gg
RecruitingNCT07813234Updated Sep 10, 2026

Prospective Evaluation of Anterior Aesthetic Rib Cage Remodeling With Osteosynthesis for Lower Anterior Thoracic Prominence

An observational study in Chest Wall Deformity and Prominent Lower Rib Cage, sponsored by Research Inc. Recruiting at 1 site in Colombia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Research Inc · Observational

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
160
Ages
18 Years and older
Sex
All
01

Study summary

This prospective single-group study will evaluate anterior aesthetic rib cage remodeling with osteosynthesis (ARCO) in adults with anteroinferior rib prominence or deformity. The procedure modifies and stabilizes ribs 6 through 8. Inferior rib cage perimeter, CT findings, spirometry, intraoperative respiratory variables, BODY-Q Chest scores, and complications will be assessed through 12 months. The primary outcomes are one-year perimeter change and major procedure-related complications.

Read the detailed description

Participants who meet standardized ARCO eligibility criteria will undergo preoperative chest CT, spirometry, anthropometry, photography, and BODY-Q assessment. During surgery, controlled greenstick remodeling of the selected anterior ribs will be followed by plate osteosynthesis. Peak inspiratory pressure and pulmonary compliance will be recorded before remodeling, during the maneuver, and after fixation, and thoracic ultrasound will assess pleural integrity. Postoperative CT will evaluate angulation, union, and hardware position; spirometry will assess pulmonary function; and standardized perimeter and BODY-Q measurements will assess aesthetic effectiveness. Complications will be actively collected through month 12.

02

Conditions studied

  • Chest Wall Deformity
  • Prominent Lower Rib Cage

Keywords

  • ARCO
  • Anterior Rib Remodeling
  • Osteosynthesis
  • Chest Wall Contouring
  • Spirometry
  • Computed Tomography
03

In context

Lead sponsor

Research Inc is the lead sponsor of 24 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults seeking correction of anteroinferior rib cage prominence or deformity who meet the standardized ARCO operative criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 45 years, or older participants with documented acceptable bone health under the final protocol.
  • Prominence, dysmorphia, or contour concern involving the anteroinferior rib cage and judged appropriate for ARCO.
  • Preoperative chest CT, spirometry, medical history, and physical examination completed.
  • 30 kg/m2 or lower.
  • Ability to comply with CT, spirometry, BODY-Q, and clinical follow-up through 12 months.
  • Written

Exclusion criteria

Exclusion Criteria:

  • Osteoarticular disease affecting rib integrity or osteoporosis risk.
  • Previous major chest surgery or significant thoracic trauma.
  • Coagulation disorder, chronic pulmonary disease, or uncontrolled systemic disease.
  • Active cancer, short , or to elective surgery.
  • Known adverse reaction to the proposed osteosynthesis material.
  • Psychiatric condition or body-image disorder that, after specialist assessment when indicated, impairs informed decision-making or realistic expectations.
  • Pregnancy or breastfeeding.
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
160 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • ARCO Procedure

    Participants undergo anterior aesthetic rib cage remodeling with controlled greenstick rib modification and plate osteosynthesis, followed by standardized 12-month assessments.

    Procedure: Anterior Aesthetic Rib Cage Remodeling With Osteosynthesis · Diagnostic Test: Chest CT and Spirometry Follow-up

Interventions

  • ProcedureAnterior Aesthetic Rib Cage Remodeling With Osteosynthesis

    Through small inframammary incisions, the lower borders of ribs 6, 7, and 8 are identified. The external cortical layer is cut using a piezoelectric device, controlled greenstick remodeling is performed, and each treated rib is stabilized with a contoured titanium plate and screws. The final surgical manual will specify treated ribs, target angle, fixation system, and verification steps. Linked arm/group(s): ARCO Procedure.

  • Diagnostic testChest CT and Spirometry Follow-up

    CT will assess rib angle, fixation, union, and thoracic complications. Spirometry will record FVC, FEV1, FEV1/FVC, peak expiratory flow, and FEF25-75 using standardized quality criteria. Linked arm/group(s): ARCO Procedure.

06

What researchers measure

Primary outcomes

  1. Change in Inferior Rib Cage Perimeter at the Eighth-Rib Level

    Circumference in centimeters will be measured using a standardized horizontal landmark at end-expiration. Three measurements will be averaged. Change is the 12-month value minus baseline; a negative value indicates perimeter reduction.

    Time frame: Baseline and postoperative month 12. 12 months

Secondary outcomes

  1. Incidence of Major ARCO-Related Complications

    Proportion of participants with pneumothorax requiring drainage, hemothorax, fixation failure requiring intervention, symptomatic nonunion/malunion, deep infection, respiratory deterioration requiring treatment, unplanned reoperation, or another serious procedure-related event.

    Time frame: From surgery through postoperative month 12. 12 months

  2. Change in Spirometric Pulmonary Function FVC

    Change in FVC from baseline. Values will be reported in liters, ratios, and percent predicted as appropriate.

    Time frame: Baseline, postoperative week 6, postoperative month 3, and postoperative month 12. 12 months

  3. CT-Confirmed Structural Stability

    Proportion of treated ribs with maintained planned angulation, stable plate and screw position, evidence of union, and no clinically significant loss of correction, nonunion, malunion, or hardware migration.

    Time frame: Postoperative week 6, postoperative month 3, and postoperative month 12 if the final radiation protocol includes the 12-month CT. 12 months

  4. Change in BODY-Q Chest Satisfaction Score

    Rasch-transformed 0-to-100 BODY-Q Chest score; higher values indicate greater satisfaction with chest appearance.

    Time frame: Baseline, postoperative day 7, postoperative month 3, and postoperative month 12. 12 months

  5. Change in Intraoperative Peak Inspiratory pressure

    Peak inspiratory pressure will be recorded at standardized ventilator settings immediately before rib remodeling, during open greenstick modification, and after definitive fixation.

    Time frame: Intraoperative: before rib remodeling, during remodeling, and after fixation during the index procedure. 1 day

  6. Change in Intraoperative Pulmonary Compliance

    dynamic pulmonary compliance will be recorded at standardized ventilator settings immediately before rib remodeling, during open greenstick modification, and after definitive fixation.

    Time frame: Intraoperative: before rib remodeling, during remodeling, and after fixation during the index procedure. 1 day

  7. Change in Spirometric Pulmonary Function FEV1

    Change in FEV1from baseline. Values will be reported in liters, ratios, and percent predicted as appropriate.

    Time frame: Baseline, postoperative week 6, postoperative month 3, and postoperative month 12. 12 months

  8. Change in Spirometric Pulmonary Function FEV1/FVC

    Change in FEV1/FVC from baseline. Values will be reported in liters, ratios, and percent predicted as appropriate.

    Time frame: Baseline, postoperative week 6, postoperative month 3, and postoperative month 12. 12 months

  9. Change in Spirometric Pulmonary Function peak expiratory flow

    Change in peak expiratory flow from baseline. Values will be reported in liters, ratios, and percent predicted as appropriate.

    Time frame: Baseline, postoperative week 6, postoperative month 3, and postoperative month 12. 12 months

  10. Change in Spirometric Pulmonary Function FEF25-75

    Change in FEF25-75 from baseline. Values will be reported in liters, ratios, and percent predicted as appropriate.

    Time frame: Baseline, postoperative week 6, postoperative month 3, and postoperative month 12. 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Aguilar Villa H, Ramirez B, Villabona-Florez SJ, Hoyos AE, Perez Pachon ME, Serrano-Reyes HM, Valdivieso CO, Valdivieso DO, Barajas-Gamboa J, Varela A, Proto R, Diaz CJ. Anterior Aesthetic Rib Cage Remodeling With Osteosynthesis. Plast Reconstr Surg Glob Open. 2025 Dec 8;13(12):e7109. doi: 10.1097/GOX.0000000000007109. eCollection 2025 Dec. PubMed 41367927 ↗

Individual participant data

Plan to share: No — not contempled in the patient informed consent

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2025 to primary completion in May 2026, 16 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 1, 2026
First posted
Sep 10, 2026
StartActual
Jan 1, 2025
Primary completionActual
May 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07813234
Lead sponsor
Research Inc
Responsible party
Sponsor
First posted
Sep 10, 2026
Start date
Jan 1, 2025
Primary completion
May 1, 2026
Completion
Dec 1, 2026 (estimated)
Last update
Sep 10, 2026

Study contacts

Hugo Aguilar, MD, Plastic surgeon
Contact
havplasticacademy@gmail.com
+57 301 6918526
Hugo Aguilar, MD, plastic surgery
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion